|
IQVIA™ Real-World Insights Bibliography
| Patient reported outcomes in psoriasis |
| Author(s): García-Díez A, Ferrandiz C, Bermudez-Rey L, Espallardo O, Lizan L, Badia X |
| Affiliations(s): |
Publication(s): ISPOR 2007 10th Annual European Congress
|
| Document Type(s): Poster, |
| Countries: Spain, |
C:
Y: |
Dermatology,
2006 |
|
L:
A: |
English
Quality of life, |
|
 |
| |
| |
| Impact of psoriasis on health-related quality of life |
| Author(s): Ferrándiz Foraster C, García-Díez A, Lizán Tudela L, Bermúdez-Rey L, Badía Llach X |
| Affiliations(s): |
Publication(s): Med Clin 2007;128(9):325-9
|
| Document Type(s): Article, |
| Countries: Spain, |
C:
Y: |
Dermatology,
2006 |
|
L:
A: |
Spanish
Quality of life, |
|
|
| |
| |
| Health system impact of Atopic Dermatitis in Spain in pediatric population. |
| Author(s): García Díez A, García-Patos Briones V, Zambrano Zambrano A, Gonzalez Hachero J, Polanco Allué I, Rodrigo Gonzalo de Liria C. |
| Affiliations(s): |
| Publication(s): |
| Document Type(s): In press/to be published, |
| Countries: Spain, |
C:
Y: |
Dermatology,
2006 |
|
L:
A: |
English
|
|
|
| |
| |
| Risk of Lymphoma Following Exposure to Calcineurin Inhibitors and Topical Steroids Inpatients with Atopic Dermatitis |
| Author(s): Arellano F, Wentworth CE, Arana A, Fernandez C, Paul C |
| Affiliations(s): |
Publication(s): Journal of Investigative Dermatology; 9 Nov 2006
|
| Document Type(s): Manuscript in preparation, |
| Countries: |
C:
Y: |
Dermatology,
2006 |
|
L:
A: |
English
|
|
|
| |
| |
| Impact of treatment with agalsidase beta treatment on health related quality of life in patients with Fabry?s disease. |
| Author(s): Badia X, Perez P, Layola M, Checa D, Tutor A, Torra R, Torras J, de Arriba G, García-Moncó C, Puig JM, Torregrosa V. |
| Affiliations(s): |
Publication(s): 13th Annual Conference of the International Society for Quality of Life Research (ISOQOL), Lisbon (Portugal) 11-14 October
|
| Document Type(s): Poster, |
| Countries: Spain, |
C:
Y: |
Dermatology,
2006 |
|
L:
A: |
English
|
|
|
| |
| |
| Cost effectiveness of etanercept in patients with plaque psoriasis meeting BAD criteria for biological interventions. |
| Author(s): Conway PA1, Reeves P2, Lloyd A2, Baxter G1. |
| Affiliations(s): 1 Wyeth Pharmaceuticals, Taplow, UK 2 Fourth Hurdle Consulting Ltd, London, UK |
Publication(s): British Association of Dermatologists 86th annual meeting, Manchester, 2006.
|
| Document Type(s): Poster, |
| Countries: UK, |
C:
Y: |
Dermatology,
2006 |
|
L:
A: |
English
Cost effectiveness, |
|
|
| |
| |
 11 of 11
|
|
